Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
About this item
Full title
Author / Creator
Publisher
United Arab Emirates: Bentham Science Publishers Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United Arab Emirates: Bentham Science Publishers Ltd
Subjects
More information
Scope and Contents
Contents
Erectile dysfunction (ED) has multifactor pathogenesis, with neurological, vascular, endocrinological and psychogenic components described. However, about 50-85% of ED population report the presence of one or more comorbidities i.e. hypertension, diabetes, cardiovascular disease, dyslipidemia which all impair endothelial function and, erection is a...
Alternative Titles
Full title
Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68923726
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68923726
Other Identifiers
ISSN
1381-6128
E-ISSN
1873-4286
DOI
10.2174/138161206778343046